Kevin Buckley is an accomplished international patent attorney and the founder of Torrey Pines Law Group. He has more than 20 years of experience as a Biopharma and Digital Health executive, lawyer, and biochemist studying immuno-oncology, RNA-derived antiviral therapeutics, and bioinformatics systems.
He has handled complex intellectual property, transactional and FDA regulatory matters in what is now the world’s largest international law firm (now known as Dentons), the largest US university, the first medical device company to obtain FDA clearance for AI-enabled breast cancer detection, and in a commercial-stage international biopharmaceutical company.
He created Torrey Pines Law Group to help his clients bring lifesaving, enduring, and commercially valuable technologies to market.
His clients include healthcare, life sciences, digital health, biotechnology, pharmaceutical, medical device, clinical and in vitro diagnostics, specialty chemical, artificial intelligence (AI), and convergence technology businesses. The "convergence" often includes Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), computer vision, neural networks, and complex algorithms.
He successfully implements pharmaceutical lifecycle management, product lifecycle management, and worldwide patent portfolio development strategies. In addition, he regularly conducts IP due diligence related to international in-licensing and out-licensing transactions inbound and outbound to Europe, China, Canada, South America, Mexico, Korea, and Japan. He also conducts due diligence related to investment funding, mergers, acquisitions, licenses, and Initial Public Offerings.
Kevin has also assisted with drafting and negotiating contracts related to distribution, supply, manufacturing, licensing, resale, collaboration, joint venture, clinical trial, product marketing, data use, safety, pharmacovigilance, right of reference, and myriad other agreements. He engages a trusted network of local and international tax, securities, corporate, regulatory, and litigation counsel when required.
Areas of focus include:
Kevin has been an academic advisor to entrepreneurship centers at the University of Pennsylvania (Wharton, Law, and Medicine), Washington University in St. Louis, and UC San Diego. He was also an Adjunct Professor at Washington University School of Law where he taught a Biotechnology Law intersession course.
When he is not in the office, you can find Kevin hiking the California backcountry or supporting San Diego County's growing community of vineyards and wineries. What he loves most, however, is spending time outdoors -- every single day -- with his daughter, family and friends.
Kevin received a Bachelor of Science degree in Biochemistry/Chemistry from UC San Diego where he was an undergraduate Research Scholar. He then received a Juris Doctorate from the University of Pittsburgh School of Law where he was Editor-in-Chief of the Pittsburgh Journal of Technology Law and Policy.
Kevin has been selected by his peers for inclusion in:
Kevin is registered to practice before the U.S. Patent & Trademark Office, and is admitted to practice law in Pennsylvania and Missouri. He is also admitted to the Federal Circuit Court of Appeals.
Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.
We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Germany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.
Biotech Patent Attorney - Medical Device Patent Preparation & Prosecution Lawyer - Pharmaceutical Intellectual Property Opinions - Complex IP Transactions - San Diego Patent Lawyer - Technology Commercialization Counsel - Pharmaceutical Patent Counsel